R-CHOP

Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone · Chemo-immunotherapy Standard Protocol

Back to Cancer Drug Encyclopedia Find Recruiting Trials with this Drug →

Indications & Uses

Standard first-line curative regimen for Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma, and High-Grade B-cell Lymphomas.

Contraindications

Active severe hepatitis B infection, severe heart failure.

Side Effects & Warnings

Severe neutropenia, infusion reactions (rituximab), cardiotoxicity (doxorubicin), peripheral neuropathy, alopecia.

Drug & Dietary Interactions

Extensive interactions; consult specific multi-agent administration and hydration protocols.

For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.

Patient & Caregiver Support

Ask About This Medication

Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.